Evidence map›Paper›PMID 29402903›Full record

ArticleScientific reports2018

Loss-of-function uORF mutations in human malignancies.

Julia Schulz, Nancy Mah, Martin Neuenschwander, Tabea Kischka, Richard Ratei, Peter M Schlag, Esmeralda Castaños-Vélez, Iduna Fichtner, Per-Ulf Tunn, Carsten Denkert and 7 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. The role of untranslated region variants in Mendelian disease: a review.European journal of human genetics : EJHG · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. The Functional Meaning of 5'UTR in Protein-Coding Genes.International journal of molecular sciences · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 1 country.

Julia SchulzMax-Delbrueck-Center for Molecular Medicine, Robert-Roessle-Str. 10, 13125, Berlin, Germany.
Nancy MahCharité University Medicine Berlin, Campus Virchow-Klinikum, Berlin-Brandenburg Center for Regenerative Therapies, Augustenburger Platz 1, 13353, Berlin, Germany.
Martin NeuenschwanderLeibniz Institute fuer Molekulare Pharmakologie, Robert-Roessle-Str. 10, 13125, Berlin, Germany.
Tabea KischkaInstitute of Bioinformatics, University of Muenster, Niels-Stensen-Straße 14, 48149, Muenster, Germany.
Richard RateiCarl-Thiem-Klinikum, 2. Medizinische Klinik, Thiemstr. 111, 03048, Cottbus, Germany.
Peter M SchlagCharité Comprehensive Cancer Center, Charitéplatz 1, 10117, Berlin, Germany.
Esmeralda Castaños-VélezCharité Comprehensive Cancer Center, Charitéplatz 1, 10117, Berlin, Germany.
Iduna FichtnerMax-Delbrueck-Center for Molecular Medicine, Robert-Roessle-Str. 10, 13125, Berlin, Germany.
Per-Ulf TunnHelios Klinikum Berlin-Buch, Schwanebecker Chaussee 50, 13125, Berlin, Germany.
Carsten DenkertCharité University Medicine Berlin, Institute of Pathology, Chariteplatz 1, 10117, Berlin, Germany.
Oliver KlaasUniversity Hospital Muenster, Department of Medicine A, Hematology, Oncology and Pneumology, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.
Wolfgang E BerdelUniversity Hospital Muenster, Department of Medicine A, Hematology, Oncology and Pneumology, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.
Jens P von KriesLeibniz Institute fuer Molekulare Pharmakologie, Robert-Roessle-Str. 10, 13125, Berlin, Germany.
Wojciech MakalowskiInstitute of Bioinformatics, University of Muenster, Niels-Stensen-Straße 14, 48149, Muenster, Germany.
Miguel A Andrade-NavarroJohannes-Gutenberg University of Mainz, Institute of Molecular Biology, Ackermannweg 4, 55128, Mainz, Germany.
Achim LeutzMax-Delbrueck-Center for Molecular Medicine, Robert-Roessle-Str. 10, 13125, Berlin, Germany. aleutz@mdc-berlin.de.ORCID http://orcid.org/0000-0001-8259-927X
Klaus WethmarMax-Delbrueck-Center for Molecular Medicine, Robert-Roessle-Str. 10, 13125, Berlin, Germany. klaus.wethmar@ukmuenster.de.
Max Delbrück Center · DECharité - Universitätsmedizin Berlin · DELeibniz-Forschungsinstitut für Molekulare Pharmakologie · DEUniversity Hospital Münster · DEBerlin-Brandenburger Centrum für Regenerative Therapien · DECarl-Thiem-Klinikum Cottbus · DEHelios Hospital Berlin-Buch · DEJohannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ribosome profiling revealed widespread translational activity at upstream open reading frames (uORFs) and validated uORF-mediated translational control as a commonly repressive mechanism of gene expression. Translational activation of proto-oncogenes through loss-of-uORF mutations has been demonstrated, yet a systematic search for cancer-associated genetic alterations in uORFs is lacking. Here, we applied a PCR-based, multiplex identifier-tagged deep sequencing approach to screen 404 uORF translation initiation sites of 83 human tyrosine kinases and 49 other proto-oncogenes in 308 human malignancies. We identified loss-of-function uORF mutations in EPHB1 in two samples derived from breast and colon cancer, and in MAP2K6 in a sample of colon adenocarcinoma. Both mutations were associated with enhanced translation, suggesting that loss-of-uORF-mediated translational induction of the downstream main protein coding sequence may have contributed to carcinogenesis. Computational analysis of whole exome sequencing datasets of 464 colon adenocarcinomas subsequently revealed another 53 non-recurrent somatic mutations functionally deleting 22 uORF initiation and 31 uORF termination codons, respectively. These data provide evidence for somatic mutations affecting uORF initiation and termination codons in human cancer. The insufficient coverage of uORF regions in current whole exome sequencing datasets demands for future genome-wide analyses to ultimately define the contribution of uORF-mediated translational deregulation in oncogenesis.

Indexed as

MutationOpen Reading FramesProto-Oncogenes5' Untranslated RegionsCarcinogenesisCell Line, TumorCodon, TerminatorGenes, ReporterGenome-Wide Association StudyHEK293 CellsHigh-Throughput Nucleotide SequencingHumansLuciferasesMAP Kinase Kinase 6Neoplasm ProteinsNeoplasms5' Untranslated RegionsCodon, TerminatorLuciferasesMAP2K6 protein, humanMAP Kinase Kinase 6Neoplasm ProteinsProtein-Tyrosine KinasesReceptor, EphB1

Identifiers

PMID29402903
PMCPMC5799362
OpenAlexW2801535989

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.